Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities

• Status: Completed
• Trial end date: 2000-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purposes of this study are to evaluate the degree and duration of medroxyprogesterone acetate effect as well as tolerability in postmenopausal women with nasal continuous positive airway pressure (CPAP) treated sleep apnea and to compare the effects with nasal CPAP.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Turku University Hospital
• Treatments: Medroxyprogesterone; Medroxyprogesterone Acetate

Criteria

Inclusion Criteria:

• postmenopausal female

• regular controls of CPAP treatment in pulmonary clinic and regular use of CPAP device

Exclusion Criteria:

• severe or unstable chronic illnesses

• heavy current smoking (over 10 cigarettes per day)

• medication which effects on the central nervous system

• contraindications to progesterone therapy and current participation in any other clinical study